Concepedia

PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trial

Michael J. Koren, Olivier Descamps, Yoshiki Hata, Ellen Margo Hengeveld, G. Kees Hovingh, Ignatios Ikonomidis, Maria D Radu Juul Jensen, Irene H. Langbakke, Fabrice M A C Martens, ANETTE L. SØNDERGAARD,

The Lancet Diabetes & Endocrinology · 2024 · 36 citations · 18 references

DOIFull text

Open access

Concepts

References

18

Inference and missing data

Donald B. Rubin · Biometrika · 1976 · 9.7K citations

, , +17

2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

François Mach, Colin Baigent, Alberico L. Catapano et al. · European Heart Journal · 2019 · 8.9K citations · Full text

, , +17

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

Neil J. Stone, Jennifer G. Robinson, Alice H. Lichtenstein et al. · Journal of the American College of Cardiology · 2013 · 3.9K citations · Full text

, , +15

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Gregory G. Schwartz, Philippe Gabríel Steg, Michael Szarek et al. · New England Journal of Medicine · 2018 · 3.5K citations · Full text

, , +17

Sequence Variations in <i>PCSK9,</i> Low LDL, and Protection against Coronary Heart Disease

Jonathan C. Cohen, Eric Boerwinkle, Thomas H. Mosley et al. · New England Journal of Medicine · 2006 · 3.2K citations · Full text

, , +17